Lambin, Thomas
Faye, Adam S.
Colombel, Jean-Frédéric
Article History
First Online: 4 August 2020
Compliance with ethical standards
:
: Thomas Lambin reports receiving grant support from Digest Science Foundation (Lille, France), receiving travel accommodation from Adacyte therapeutics. Adam S Faye reports receiving grant support from NIH: T32DK083256. Jean-Frédéric Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, O Mass, Pfizer, SERENE CD, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.
: This article does not contain any studies with human or animal subjects performed by any of the authors.